Drug profile · INN
demeclocycline hydrochloride
DECLOMYCIN
demeclocycline hydrochloride (DECLOMYCIN) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — demeclocycline hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
demeclocycline hydrochloride (DECLOMYCIN) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is demeclocycline hydrochloride?
demeclocycline hydrochloride (DECLOMYCIN) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for demeclocycline hydrochloride?
DECLOMYCIN is a marketed brand name for demeclocycline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of demeclocycline hydrochloride?
demeclocycline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.